4519.T - Chugai Pharmaceutical Co Ltd
JPMorgan
Chugai Pharmaceutical (4519) Media report suggests GYM329 will not progress to Phase 3 for SMA/FSHD; excessive share price decline would present opportunity to buy
公司
4519.T
日期
2026-03-22
分析师
Mr. Seiji Wakao
页数
8 页
需要登录
请登录后购买研报或生成音频内容。